Phase II study of dibromodulcitol (NSC-104800).
D000328:Adult; D000368:Aged; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007970:Leukopenia / Q000139:chemically induced; D008297:Male; D008875:Middle Aged; D008936:Mitolactol / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use* / Q000633:toxicity; D009325:Nausea / Q000139:chemically induced; D009369:Neoplasms / Q000188:drug therapy*; D013921:Thrombocytopenia / Q000139:chemically induced; D013997:Time Factors; D014839:Vomiting / Q000139:chemically induced
D008936:Mitolactol